Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

0.5477
Delayed Data
As of Jun 30
 +0.0077 / +1.43%
Today’s Change
0.44
Today|||52-Week Range
3.72
-38.97%
Year-to-Date
Sunesis Pharmaceuticals (SNSS) in Focus: Stock Gains 8.7%
Jun 21 / Zacks.com - Paid Partner Content
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.54
Today’s open0.60
Day’s range0.55 - 0.60
Volume169,178
Average volume (3 months)245,487
Market cap$47.6M
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+34.21%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-46.62%
P/E ratioNM
Price/Sales21.38
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.01+0.74%
AXNAoxing Pharmaceutica...+0.02+2.36%
CASICASI Pharmaceuticals...+0.07+6.36%
IMMYImprimis Pharmaceuti...+0.06+1.62%
Data as of 4:01pm ET, 06/30/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$3.1M
Annual profit (last year)-$36.7M
Net profit margin-1,198.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs